Ligand validation:2WGG

TLM: THIOLACTOMYCIN

TLM is a Ligand Of Interest in 2WGG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WGG_TLM_A_1417	89%	10%	0.095	0.973	1.75	2.5	1	4	0	0	100%	1
2WGG_TLM_G_1419	88%	4%	0.091	0.968	2.52	3.27	2	4	0	0	100%	1
2WGG_TLM_H_1417	87%	12%	0.088	0.96	1.92	2.18	1	4	0	0	100%	1
2WGG_TLM_B_1419	87%	9%	0.085	0.955	2.18	2.35	2	5	0	0	100%	1
2WGG_TLM_F_1417	84%	8%	0.087	0.948	1.75	2.85	1	4	0	0	100%	1
2WGG_TLM_E_1417	83%	11%	0.104	0.962	1.87	2.32	1	3	0	0	100%	1
2WGG_TLM_C_1417	83%	13%	0.101	0.958	1.9	2.02	2	4	0	0	100%	1
2WGG_TLM_D_1417	79%	9%	0.116	0.961	1.75	2.65	1	4	0	0	100%	1
4C6X_TLM_B_1418	81%	49%	0.11	0.961	0.63	1.31	-	1	0	0	100%	1
2WGE_TLM_A_1424	55%	6%	0.17	0.94	1.88	3.04	2	3	7	0	100%	0.75
2VB8_TLM_B_1405	91%	38%	0.079	0.965	0.72	1.69	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.